comsteincomstein
Marketplace
MPModicus Prime logo

AI software · Modicus Prime

Promote Modicus Prime

Modicus Prime

AI compliance platform for deploying auditable AI in GxP-regulated pharmaceutical manufacturing.

Open for PartnersAI complianceGxPpharmaceutical manufacturingbiologicscomputer visionListed since May 2026

Partner summary

The offer at a glance

A quick read on buyer fit, pitch, economics, and promotion fit.

Best buyer

Pharma Quality & Compliance Leaders

Main outcome

Stay compliant as you scale AI across the organization.

Commission

To be confirmed

Best channels

Direct Outreach To Pharma And Biologics Quality, Validation, And Digital Leaders, Warm Introductions Through Life Sciences Networks, Industry Events And Conferences In Pharma Manufacturing And AI/ML, Content Marketing Focused On AI In GxP

Terms

Founder confirmation required before promotion.

Main pitch

Modicus Prime is the compliance-first AI lifecycle platform for pharma and biologics manufacturers. It supports both the compliance and technical requirements of AI/ML in GxP...

Economics

Partner terms

Commission, pricing model, and review timing for this listing.

Commercial terms

Partner terms

Founder confirmation required before partners promote this listing.

Commission
To be confirmed
Pricing
Subscription
Duration
Review period
30 days

Pricing tiers

Enterprise (contact sales)

Primary

Custom/ month

Tracks Demo Request

  • Life cycle oversight for AI/ML in GxP environments
  • Change management for AI models
  • Regulatory compliance support
  • Optional AI submodules
  • mpVision computer vision for imaging QC

Who this converts for

The buyers this offer is shaped for. Match your reach to the strongest audience fit.

high
B2C

Pharma Quality & Compliance Leaders

Quality, validation, and compliance leaders at pharmaceutical and biologics manufacturers responsible for ensuring AI/ML systems meet GxP requirements.

Pharmaceutical ManufacturingVP of QualityHead of Validation

Pain points

  • No standard framework for governing AI/ML systems under GxP
  • Manual documentation and audit trails for AI model changes
  • Risk of regulatory findings when deploying ML in production manufacturing
  • AI pilots stall when they hit GxP validation gates
  • Slow, manual review of biologics imaging data
  • Cost, legal, and waste liabilities from product quality failures

Desired outcomes

  • Auditable AI lifecycle from concept to ongoing monitoring
  • Defensible change management for models in GxP environments
  • Faster, lower-risk path to deploying AI in commercial manufacturing
  • Defensible change management for AI models in regulated production
  • Real-time classification of imaging data for QC across R&D and manufacturing
medium
B2C

Biopharma AI/ML & Digital Transformation Leaders

Digital, AI, and data science leaders inside biopharma that own AI/ML deployment into regulated manufacturing and need a compliant lifecycle around their models.

BiopharmaceuticalsChief Digital OfficerHead of AI/ML

Pain points

  • AI pilots stall when they hit GxP validation gates
  • Lack of tooling for representative data sets, training, and monitoring under GAMP
  • Hard to maintain a state of control for models in production

Desired outcomes

  • Move AI/ML projects from concept through operations with compliance built in
  • Standardize AI lifecycle across sites and product lines
  • Translate GAMP principles into day-to-day practice
medium
B2C

Biologics Manufacturing & Process Development Teams

Manufacturing, process development, and MSAT teams in biologics that use imaging and computer vision for quality control and contamination detection.

Biologics ManufacturingHead of Process DevelopmentDirector of MSAT

Pain points

  • Slow, manual review of biologics imaging data
  • Cost, legal, and waste liabilities from product quality failures
  • Difficulty operationalizing computer vision under GxP

Desired outcomes

  • Real-time classification of imaging data for QC
  • Automated biologics image analysis across R&D and manufacturing
  • Lower scrap and faster release decisions

VP of Quality

Deploy and scale AI/ML in GxP-regulated pharmaceutical and biologics manufacturing in a way that is auditable, compliant, and operationally useful for quality control.

VP of QualityHead of Validation

Heads of Quality and Validation at top-25 pharma manufacturers

Deploy and scale AI/ML in GxP-regulated pharmaceutical and biologics manufacturing in a way that is auditable, compliant, and operationally useful for quality control.

VP of QualityHead of Validation

Digital and AI leaders at biologics CDMOs

Deploy and scale AI/ML in GxP-regulated pharmaceutical and biologics manufacturing in a way that is auditable, compliant, and operationally useful for quality control.

VP of QualityHead of Validation

Why partners convert here

When to pitch this, and the outcomes the buyer actually gets.

Use cases

  • Govern the AI/ML lifecycle in GxP environments
  • Govern the AI/ML lifecycle in GxP environments
  • Deploy auditable computer vision for biologics quality control
  • Deploy auditable computer vision for biologics quality control
  • Manage change control for AI models in production
  • Manage change control for AI models in production

Outcomes

Stay compliant as you scale AI across the organization.

Evidence

Improve quality metrics and reduce commercial production costs through compliant AI deployment.

Evidence

Real-time classification of biologics imaging data, from morphology analysis to commercial contamination detection.

Evidence

Auditable AI lifecycle from concept to ongoing monitoring

Defensible change management for AI models in regulated production

Real-time classification of imaging data for QC across R&D and manufacturing

Faster, lower-risk path to deploying AI in commercial manufacturing

Strategic partnerships across pharma and AI/ML ecosystem

Evidence

Co-authored AI-in-GxP industry publications

Evidence

ISPE GAMP AI/ML in Regulated Life Sciences webinar series

Evidence

mpVision globally tested by scientists at Takeda Pharmaceuticals

Evidence

Membership in Johnson & Johnson Innovation–JLABS network

Evidence

Before · After

Govern the AI/ML lifecycle in GxP environments

Before

AI/ML projects in pharma manufacturing lack a consistent, auditable lifecycle, making validation and regulator engagement slow and risky.

After

A compliance-first platform that covers life cycle oversight, change management, and regulatory compliance for AI/ML in GxP environments.

Expected outcome: Auditable AI deployments that hold up under quality and regulatory review.

What makes this different

Where this offer beats the alternatives.

  • Purpose-built for AI/ML in GxP environments

  • Covers both compliance and technical lifecycle in one platform

  • mpVision computer vision tested by scientists at Takeda Pharmaceuticals

  • Co-authored ISPE GAMP AI Guide and BioPhorum AI Implementation publication

  • Strategic partnerships across pharma, accelerators, and national labs

Promotion strategy

Partner playbook

Angles, questions, objections, and inputs to keep outreach sharp.

Value proposition

AI compliance platform for deploying auditable AI in GxP-regulated pharmaceutical manufacturing.

How to pitch

Modicus Prime is the compliance-first AI lifecycle platform for pharma and biologics manufacturers. It supports both the compliance and technical requirements of AI/ML in GxP environments, with life cycle oversight, change management, and regulatory compliance, plus mpVision computer vision for real-time imaging QC. Position it to Quality, Validation, and Digital leaders who need to deploy AI without slowing down regulatory readiness.

Positioning

The compliance-first AI lifecycle management platform for GxP-regulated pharmaceutical and biologics manufacturing.

Best angles to test

  • Auditable AI as a precondition to scaling AI in commercial manufacturing
  • Bridging GAMP guidance into day-to-day AI/ML practice
  • Computer vision QC tested at a top-tier pharma scientist community
  • Compliance-first as a way to unblock stalled AI pilots
  • Modicus Prime is an AI compliance platform for deploying auditable AI in manufacturing.
  • The platform supports both the compliance and technical requirements of AI/ML implementation in GxP-regulated environments.
  • Modicus Prime helps teams stay compliant as they scale AI across the organization.
  • mpVision enables real-time classification of imaging data, from biologic morphology analysis to commercial contamination detection.
  • Modicus Prime has strategic partnerships with organizations including Takeda Pharmaceuticals, Oak Ridge National Laboratory, eLabNext (Eppendorf), Dotmatics, PlugandPlay Health, and Techstars.

Angles to avoid

  • Do not claim guaranteed regulatory approval or audit pass
  • Do not claim specific cost savings or quality metric improvements as typical
  • Do not claim official partnership with regulators
  • Do not claim Modicus Prime is FDA-endorsed or pre-cleared
  • Do not claim guaranteed revenue or partner payouts

Discovery questions

  • Where in your AI/ML lifecycle do GxP validation requirements slow you down?
  • How are you currently handling change control for AI models in production?
  • Which imaging-based QC workflows would benefit most from real-time AI classification?
  • What is your roadmap for scaling AI across multiple manufacturing sites?

Disqualifiers

  • Non-life-sciences companies
  • unregulated consumer AI use cases
  • or pre-product startups without active AI/ML in regulated environments.

Target keywords

AI complianceGxP AIAI lifecycle managementGAMP AI/MLpharmaceutical AIbiologics computer visionAI quality controlregulated AI deploymentmpVisionAI change management

Objections & responses

  • We already have CSV/CSA processes — do we really need an AI-specific platform?

    Response: Existing CSV/CSA frameworks were not designed for the iterative nature of AI/ML systems. Modicus Prime extends those processes with lifecycle oversight and change management specific to AI models so retraining, drift, and updates remain auditable.

  • We are still piloting AI — it is too early for a compliance platform.

    Response: Modicus Prime is designed to be introduced during the concept and project phases so AI/ML systems are built with auditable practices from the start, rather than retrofitted before commercial scale-up.

  • Will adopting Modicus Prime slow down our scientists?

    Response: mpVision is positioned as a self-service platform that lets scientists train their own AI for real-time imaging classification, with compliance support layered on top instead of replacing their workflow.

Rules

Promotion rules

Where you can promote, what is restricted, and what the founder requires.

Allowed channels

Direct Outreach To Pharma And Biologics Quality, Validation, And Digital LeadersWarm Introductions Through Life Sciences NetworksIndustry Events And Conferences In Pharma Manufacturing And AI/MLContent Marketing Focused On AI In GxP

Restricted channels

Unsolicited Cold Outreach To RegulatorsPaid Search Bidding On Modicus Prime Brand TermsMass Cold Email CampaignsSocial Media Ads Targeting Patients Or Unrelated Consumer Audiences
AI-generated content
Yes
Content reuse
No
Founder approval
Yes

Approved claims

  • Modicus Prime is an AI compliance platform for deploying auditable AI in manufacturing.
  • The platform supports both the compliance and technical requirements of AI/ML implementation in GxP-regulated environments.
  • Modicus Prime helps teams stay compliant as they scale AI across the organization.
  • mpVision enables real-time classification of imaging data, from biologic morphology analysis to commercial contamination detection.
  • Modicus Prime has strategic partnerships with organizations including Takeda Pharmaceuticals, Oak Ridge National Laboratory, eLabNext (Eppendorf), Dotmatics, PlugandPlay Health, and Techstars.

Claims to avoid

  • Do not claim guaranteed regulatory approval or audit pass
  • Do not claim specific cost savings or quality metric improvements as typical
  • Do not claim official partnership with regulators
  • Do not claim Modicus Prime is FDA-endorsed or pre-cleared
  • Do not claim guaranteed revenue or partner payouts

Evidence

Proof & trust signals

Claims, evidence links, and operational trust signals partners can lean on.

Proof points

  • Stay compliant as you scale AI across the organization.
  • Improve quality metrics and reduce commercial production costs through compliant AI deployment.
  • Real-time classification of biologics imaging data, from morphology analysis to commercial contamination detection.
  • Auditable AI lifecycle from concept to ongoing monitoring
  • Defensible change management for AI models in regulated production
  • Real-time classification of imaging data for QC across R&D and manufacturing
  • Faster, lower-risk path to deploying AI in commercial manufacturing
  • Strategic partnerships across pharma and AI/ML ecosystem
  • Co-authored AI-in-GxP industry publications
  • ISPE GAMP AI/ML in Regulated Life Sciences webinar series
  • mpVision globally tested by scientists at Takeda Pharmaceuticals
  • Membership in Johnson & Johnson Innovation–JLABS network

Proof links

About Modicus Prime

Modicus Prime is a compliance-first AI lifecycle management platform purpose-built for GxP-regulated pharmaceutical and biologics manufacturing. It covers life cycle oversight, change management, regulatory compliance, and optional AI submodules, and pairs with mpVision computer vision software so scientists can train AI to classify imaging data in real time for quality control across R&D and commercial production.

modicusprime.comListed since May 2026

More offers in AI software

Other listings partners commonly compare against this one.

Browse marketplace

Listing transparency

Company activation will confirm the remaining commercial and tracking details.

Screenshots or video